Listen to this article
Moon Surgical received CE mark approval in Europe for the latest version of its Maestro surgical robot.
The initial version of Maestro received CE mark approval earlier this year in April. This milestone marks the latest in a string of positive updates for Moon Surgical, which raised $55.4 million in May. The company also announced at that time that it appointed surgical robotics veteran Fred Moll to its board.
Paris-based Moon Surgical said the updated Maestro system features enhanced scalability and refined aesthetics. Other improvements over its previous iteration include an automated set-up with bedside guidance and tailored surgeon configurations.
Additionally, the new Maestro features cloud connectivity for a more integrated operating room and ecosystem experience. It provides surgeon-guided, hands-free scope control for optimized vision capabilities.
Moon Surgical said its new category of robotic surgery aims to broaden the scale of robotic use and improve the quality of care for patients and the bottom line for healthcare providers. It designed Maestro to provide an accessible, enhanced version of traditional laparoscopy.
The platform acts as a robotic surgical assistant to augment the precision and control of laparoscopic surgery. Moon Surgical’s small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allows for alternative labor models.
“This latest evolution of the Maestro System focuses on manufacturing scalability, together with increased capability and has simplified both usability and training,” said Anne Osdoit, CEO of Moon Surgical. “It seamlessly integrates into OR workflows while giving surgeons more confidence and delivering an improved surgical experience.”
Editor’s Note: This article was originally published in our sister publication Mass Device.